Log In
BCIQ
Print this Print this
 

MAXY-4

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionCTLA4-Ig protein
Molecular Target CD80 (B7-1) ; CD86 (B7-2)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/06/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today